Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Selective 15-LO inhibitor effective in animal model of atherosclerosis

July 18, 1997

Orally active ET antagonist from BMS in clinical trials

July 18, 1997

Nippon Shinyaku reveals new series of carboxylic acid derivatives

July 18, 1997

Yamanouchi discloses Na+/H+-exchange inhibitors for cardiovascular indications

July 18, 1997

Agents for increasing HDL cholesterol from American Home Products

July 18, 1997

Zambon develops dual ACE/NEP inhibitors

July 18, 1997

New cardiovascular drugs reported by Yamanouchi

July 17, 1997

Kanebo reports novel cell adhesion inhibitors

July 17, 1997

Dual mechanism of action for antiatherosclerotic compound Org-13061

July 16, 1997

Eclipse submits PMA for Transmyocardial Revascularization procedure

July 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...